Literature DB >> 9523558

Role of oxidative stress and the glutathione system in loss of dopamine neurons due to impairment of energy metabolism.

G D Zeevalk1, L P Bernard, W J Nicklas.   

Abstract

Alterations in the glutathione system and impairment in energy metabolism have both been implicated in the loss of dopamine neurons in Parkinson's disease. This study examined the importance of cellular glutathione and the involvement of oxidative stress in the loss of mesencephalic dopamine and GABA neurons due to inhibition of energy metabolism with malonate, the reversible, competitive inhibitor of succinate dehydrogenase. Consistent with previous findings, exposure to malonate for 24 h followed by 48 h of recovery caused a dose-dependent loss of the dopamine population with little effect on the GABA population. Toxicity was assessed by simultaneous measurement of the high-affinity uptake of [3H]dopamine and [14C]GABA. Total glutathione content in rat mesencephalic cultures was decreased by 65% with a 24-h pretreatment with 10 microM buthionine sulfoxamine. This reduction in glutathione level greatly potentiated damage to both the dopamine and GABA populations and removed the differential susceptibility between the two populations in response to malonate. These findings point to a role for oxidative stress occurring during energy impairment by malonate. Consistent with this, several spin-trapping agents, alpha-phenyl-tert-butyl nitrone and two cyclic nitrones, MDL 101,002 and MDL 102,832, completely prevented malonate-induced damage to the dopamine neurons in the absence of buthionine sulfoxamine. The spin-trapping agents also completely prevented toxicity to both the dopamine and GABA populations when cultures were exposed to malonate after pretreatment with buthionine sulfoxamine to reduce glutathione levels. Counts of tyrosine hydroxylase-positive neurons verified enhancement of cell loss by buthionine sulfoxamine plus malonate and protection against cell loss by the spin-trapping agents. NMDA receptors have also been shown to play a role in malonate-induced dopamine cell loss and are associated with the generation of free radicals. Consistent with this, toxicity to the dopamine neurons due to a 1-h exposure to 50 microM glutamate was attenuated by the nitrone spin traps. These findings provide evidence for an oxidative challenge occurring during inhibition of energy metabolism by malonate and show that glutathione is an important neuroprotectant for midbrain neurons during situations when energy metabolism is impaired.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9523558     DOI: 10.1046/j.1471-4159.1998.70041421.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

2.  Liposomal-glutathione provides maintenance of intracellular glutathione and neuroprotection in mesencephalic neuronal cells.

Authors:  Gail D Zeevalk; Laura P Bernard; F T Guilford
Journal:  Neurochem Res       Date:  2010-06-10       Impact factor: 3.996

Review 3.  Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance.

Authors:  Kyung-Jin Kim; Phillip L Pearl; Kimmo Jensen; O Carter Snead; Patrizia Malaspina; Cornelis Jakobs; K Michael Gibson
Journal:  Antioxid Redox Signal       Date:  2011-04-10       Impact factor: 8.401

4.  Pterostilbene ameliorates intracerebroventricular streptozotocin induced memory decline in rats.

Authors:  Bhagyashree Naik; Abhijit Nirwane; Anuradha Majumdar
Journal:  Cogn Neurodyn       Date:  2016-09-30       Impact factor: 5.082

5.  In vitro neuroprotection against oxidative stress by pre-treatment with a combination of dihydrolipoic acid and phenyl-butyl nitrones.

Authors:  Michael L Koenig; James L Meyerhoff
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

6.  Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.

Authors:  Tomás González-Hernández; Ignacio Cruz-Muros; Domingo Afonso-Oramas; Josmar Salas-Hernandez; Javier Castro-Hernandez
Journal:  Front Neuroanat       Date:  2010-10-20       Impact factor: 3.856

7.  Catecholamine neuron groups in rat brain slices differ in their susceptibility to excitatory amino acid induced dendritic degeneration.

Authors:  P T Bywood; S M Johnson
Journal:  Neurotox Res       Date:  2001-11       Impact factor: 3.911

8.  Reactive oxygen species generation by the ethylene-bis-dithiocarbamate (EBDC) fungicide mancozeb and its contribution to neuronal toxicity in mesencephalic cells.

Authors:  Lisa M Domico; Keith R Cooper; Laura P Bernard; Gail D Zeevalk
Journal:  Neurotoxicology       Date:  2007-05-22       Impact factor: 4.294

9.  Consequences of impaired purine recycling in dopaminergic neurons.

Authors:  J C Lewers; I Ceballos-Picot; T L Shirley; L Mockel; K Egami; H A Jinnah
Journal:  Neuroscience       Date:  2008-01-17       Impact factor: 3.590

10.  Effect of microglia activation on dopaminergic neuronal injury induced by manganese, and its possible mechanism.

Authors:  Mingchao Liu; Tongjian Cai; Fang Zhao; Gang Zheng; Qiang Wang; Yaoming Chen; Chuanshu Huang; Wenjing Luo; Jingyuan Chen
Journal:  Neurotox Res       Date:  2009-03-25       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.